Manila warehouse yields fake drugs wrapped in Pacman’s brand | Inquirer News

Manila warehouse yields fake drugs wrapped in Pacman’s brand

The National Bureau of Investigation (NBI) recently seized caches of counterfeit drugs in Manila, including tablets packaged as a brand of pain relievers endorsed by boxing superstar Manny Pacquiao.

A raid last week by the NBI’s Intellectual Property Rights Division on a warehouse on Zamora Street in the Paco district yielded fake Dolfenal, Bioflu and Alaxan 200 tablets.

Two other warehouses were raided by the NBI in Pasig City and Tondo, Manila, but both operations yielded negative results.

Article continues after this advertisement

The crackdown stemmed from the complaint filed by United Laboratories Inc. (Unilab), the local distributor of the drugs, and by virtue of a search warrant issued by Judge Joselito Villarosa of Makati City Regional Trial Court Branch 66.

FEATURED STORIES

The Paco warehouse, which the NBI said was owned by Salem Maruji Ahmad, yielded 38,000 tablets packaged as Dolfenal, 60,500 tablets packed as Bioflu and 53,000 tablets packed as Alaxan, the last a brand endorsed by the famous boxer and politician.

If sold to unknowing consumers, the seized drugs could fetch a total price of P1.7 million, the NBI said.

Article continues after this advertisement

The NBI-IPRD said Ahmad, who was not found during the raid and remained at large, will be charged with trademark infringement and violation of intellectual property laws.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Drugs, fake

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.